Codiak BioSciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
CDAK Nasdaq 8731 http://www.codiakbio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Codiak BioSciences Inc

Codiak BioSciences to Participate 5th Annual Evercore ISI HealthCONx Conference - Nov 28th, 2022 6:00 pm
Codiak Presents Preclinical Data on exoASO™-STAT6 and exoASO™-C/EBPβ Programs at the Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting - Nov 10th, 2022 2:00 pm
Codiak BioSciences Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag - Nov 9th, 2022 11:11 am
Codiak BioSciences, Inc. (CDAK) Reports Q3 Loss, Lags Revenue Estimates - Nov 3rd, 2022 9:45 pm
Codiak BioSciences Reports Third Quarter 2022 Financial Results and Operational Progress - Nov 3rd, 2022 8:01 pm
Vertex (VRTX) Beats on Q3 Earnings, Ups 2022 Sales Guidance - Oct 28th, 2022 4:07 pm
BioMarin (BMRN) Q3 Earnings Beat, Sales Miss, Ups Voxzogo View - Oct 27th, 2022 4:26 pm
Biogen (BIIB) Beats on Q3 Earnings & Sales, Raises 2022 Outlook - Oct 25th, 2022 5:59 pm
All You Need to Know About Codiak BioSciences, Inc. (CDAK) Rating Upgrade to Strong Buy - Oct 19th, 2022 4:00 pm
Vertex Pharmaceuticals' (VRTX) New AAT Corrector Enters Clinic - Oct 12th, 2022 4:11 pm
Codiak Presents Preclinical Data Demonstrating its Pan Beta-Coronavirus Vaccine Elicits Broad Protective Immunity Against Known Variants of SARS-CoV-2 and Related Sarbecoviruses - Oct 12th, 2022 12:00 pm
GSK's (GSK) Boostrix Gets FDA Nod for Pertussis in Newborns - Oct 10th, 2022 3:21 pm
Biohaven (BHVN) Stock Up on Spin-Off Transaction Finalization - Oct 6th, 2022 2:54 pm
Codiak to Present New Preclinical Data Demonstrating Potent Monotherapy Activity of Two Engineered Exosome Intravenous Candidates Targeting Macrophages - Oct 5th, 2022 12:00 pm
Codiak Announces Pricing of $20 Million Public Offering of Common Stock and Warrants - Sep 13th, 2022 1:05 am
Codiak Announces Proposed Public Offering of Common Stock and Warrants - Sep 12th, 2022 8:01 pm
Codiak BioSciences Announces Program Reprioritization and Corporate Restructuring - Aug 30th, 2022 1:10 pm
Codiak BioSciences, Inc. (CDAK) Reports Q2 Loss, Tops Revenue Estimates - Aug 4th, 2022 9:15 pm
Codiak BioSciences Reports Second Quarter 2022 Financial Results and Operational Progress - Aug 4th, 2022 8:01 pm
Codiak BioSciences to Participate in Upcoming BTIG and Wedbush PacGrow Investor Conferences - Aug 3rd, 2022 8:15 pm